Skip to main content
Clinical Trials/NCT06440031
NCT06440031Not yet recruitingNot Applicable

Culturally-adapted Manual-assisted Psychological Intervention (CaMaPi) for Adolescents/Young People With a History of Self-harm and Suicidal Ideation in Jos, Nigeria

Nottingham Trent University0 sites32 target enrollmentStarted: July 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
32
Primary Endpoint
Change in acceptance and satisfaction with the intervention

Study Overview

Brief Summary

Suicide and self-harm are global disease burden that contributes significantly to years of lost life and mortality.

Detailed Description

Self-harm and suicidal ideation represent a significant global public health concern (Knipe et al., 2022), affecting about 14.6 million people yearly (Nichols et al., 2021). Globally, over 700 000 people die by suicide annually (World Health Organization -- WHO, 2023).

Suicide is the fourth leading cause of death among 15-29-year-olds, and 77% of global suicides occur in low- and middle-income countries, including Nigeria (WHO, 2023). The psychological impact of suicidal ideation includes continuing high tendencies of self-harm (Jidong et al., 2024).

Despite the increasing rates of suicide and self-harm in Nigeria, this topic is understudied, with no culturally appropriate or sustainable psychological interventions.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
16 Years to 24 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patients aged 16-24 years presenting to the participating services, and emergency departments or admitted after an episode of self-harm to the participating hospitals or self-referrals.
  • •Participants will have to be living within the catchment area of the participating practices, services and hospitals.
  • •Not needing inpatient psychiatric treatment.

Exclusion Criteria

  • •Severe mental illness (such as Psychotic disorder).
  • •Conditions limiting engagement with assessment/intervention.
  • •Temporary resident unlikely to be available for follow up.

Arms & Interventions

CaMaPi

Experimental

Intervention: CaMaPi (Behavioral)

TAU

Active Comparator

Intervention: TAU (Other)

Outcomes

Primary Outcomes

Change in acceptance and satisfaction with the intervention

Time Frame: Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention

Primary outcome measure would be assessed using the Service Satisfaction Scale

Secondary Outcomes

  • Change in hopelessness(Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention)
  • Change in repetition rate's of self-harm(Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention)
  • Change in Health Status(Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention)
  • Change in use of health services(Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention)
  • Change in psychological distress(Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention)
  • Change in suicidal ideation(Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr Dung Jidong, PhD

Dr

Nottingham Trent University

Similar Trials